18 patents
Utility
Methods for Assaying and Measuring the Efficacy of Anti-nausea Compounds
4 Jan 24
This invention is for methods to quantify the inhibition of 5-HT induced contraction of human intestinal smooth muscle and an assay to measure the effects of compounds on nausea, irritable bowel syndrome and irritable bowel disease.
Trevor Percival Castor
Filed: 15 Nov 21
Utility
Enhanced Gingerols for Patients Suffering from Nausea and Emesis
28 Dec 23
This invention relates to a composition of matter using enhanced gingerols for treating nausea and emesis associated with cancer chemotherapy, pregnancy, elective surgery, radiation therapy, motion sickness, and drug medications, use and schedule of use as well as methods of making.
Trevor Percival Castor
Filed: 15 Nov 21
Utility
Bryoid Compositions, Methods of Making and Use Thereof
10 Aug 23
Embodiments of the present invention feature novel Bryoid compositions, methods of making and methods of treating disease.
Trevor Percival Castor
Filed: 3 Apr 23
Utility
Dosage Forms for Improving Organ Transplantation, Graft Versus Host Disease and Stem Cells Transplants
4 May 23
Embodiments of the present invention are directed to dosage forms for treating inflammation and rejection in transplantation injuries, graft versus host disease and stem cell transplants with Bryostatin-1, Bryostatin-1 analogs and pharmaceutically acceptable salts thereof.
Trevor Percival Castor
Filed: 12 Mar 20
Utility
Bryoid compositions, methods of making and use thereof
2 May 23
Embodiments of the present invention feature novel Bryoid compositions, methods of making and methods of treating disease.
Trevor Percival Castor
Filed: 21 Mar 21
Utility
Methods for and Products from Encapsulation of Drugs In Nanoparticles In a Microgravity Environment
6 Oct 22
This invention relates to methods for and products from precision manufacturing targeted nanoencapsulated drugs in a microgravity environment utilizing green, environmental-friendly SuperFluids™.
Trevor Percival Castor
Filed: 4 Apr 21
Utility
Bryoid Compositions, Methods of Making and Use Thereof
22 Sep 22
Embodiments of the present invention are directed to drug delivery systems, dosage forms and methods for the intranasal administration of Bryostatins for the treatment of neuro-degenerative diseases.
Trevor Percival Castor
Filed: 27 Jun 21
Utility
Nanoencapsulated Cannabidiol
15 Sep 22
Embodiments of the present invention are directed to articles of manufacture and methods of making such articles having utility for the delivery of cannabinoids, naltrexone and a combination of cannabinoids and naltrexone as a therapeutic.
Trevor Percival Castor
Filed: 15 Aug 20
Utility
Combination Therapeutics and Methods for the Treatment of Neurodegenerative and Other Diseases
12 May 22
Embodiments of the present invention are directed to the administration of co-encapsulated bryostatins and retinoids for the treatment of disease, wherein the co-encapsulated bryostatins and retinoids synergistically increase expression of alpha secretase activity in patients.
Trevor Percival Castor
Filed: 7 Nov 20
Utility
Combination HIV therapeutic
1 Feb 22
Embodiments of the present invention are directed to particles having a Bryoid and a HDAC inhibitor for the treatment of latent viral disease.
Trevor Percival Castor
Filed: 27 Nov 19
Utility
Methods and Products for Treating Folic Acid Deficiency and Morning Sickness
20 Jan 22
Embodiments of the present invention are directed to formulations and methods of treating folic acid deficiency and morning sickness.
Trevor P Castor
Filed: 5 Dec 19
Utility
Bryoid Compositions, Methods of Making and Use Thereof
2 Sep 21
Embodiments of the present invention feature novel Bryoid compositions, methods of making and methods of treating disease.
Trevor Percival Castor
Filed: 21 Mar 21
Utility
Bryoid compositions, methods of making and use thereof
23 Mar 21
Embodiments of the present invention feature novel Bryoid compositions, methods of making and methods of treating disease.
Trevor Percival Castor
Filed: 4 Dec 18
Utility
Drug delivery system and method for the treatment of neuro-degenerative disease
23 Dec 20
Embodiments of the present invention are directed to drug delivery systems, dosage forms and methods for the intranasal administration of Bryostatins for the treatment of neuro-degenerative diseases.
Trevor Percival Castor, Jonathan Steven Alexander
Filed: 21 Nov 19
Utility
Combination therapeutics and methods for the treatment of neurodegenerative and other diseases
9 Nov 20
Embodiments of the present invention are directed to the administration of bryostatins and bryostatins and retinoids for the treatment of disease responsive to increases in alpha secretase activity.
Trevor Percival Castor
Filed: 25 Nov 13
Utility
Transplantation therapies
27 Jul 20
Embodiments of the present invention are directed to methods and dosage forms for treating inflammation and rejection in transplantation injuries with Bryostatin-1, Bryostatin-1 analogs and pharmaceutically acceptable salts thereof.
Jonathan Steven Alexander, April C. Carpenter, Trevor Percival Castor
Filed: 7 Jun 18
Utility
Transplantation Therapies
24 Jun 20
Embodiments of the present invention are directed to methods and dosage forms for treating inflammation and rejection in transplantation injuries with Bryostatin-1, Bryostatin-1 analogs and pharmaceutically acceptable salts thereof.
Jonathan Steven Alexander, April C. Carpenter, Trevor Percival Castor
Filed: 4 Mar 20
Utility
Transplantation Therapies
24 Jun 20
Embodiments of the present invention are directed to methods and dosage forms for treating inflammation and rejection in transplantation injuries with Bryostatin-1, Bryostatin-1 analogs and pharmaceutically acceptable salts thereof.
Jonathan Steven Alexander, April C. Carpenter, Trevor Percival Castor
Filed: 4 Mar 20
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first